Rxo (RXO) Share-based Compensation (2021 - 2026)

Rxo (RXO) has reported Share-based Compensation for 6 consecutive years, with $7.0 million the latest figure, recorded in Q1 2026.

• Share-based Compensation for Q1 2026 came in at $7.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.0 million (up 16.0% YoY), and the FY2025 annual result was $29.0 million, up 26.09% from the prior year.
• Share-based Compensation was $7.0 million for Q1 2026 at Rxo, roughly flat from $7.0 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $23.0 million in Q4 2022 and troughed at $2.0 million in Q1 2022.
• Average Share-based Compensation over 5 years is $6.5 million, with a median of $6.0 million recorded in 2023.
• Year-over-year, Share-based Compensation jumped 1050.0% in 2022 and plunged 86.96% in 2023.
• Over 5 years, Share-based Compensation stood at $23.0 million in 2022, then slumped by 86.96% to $3.0 million in 2023, then surged by 100.0% to $6.0 million in 2024, then climbed by 16.67% to $7.0 million in 2025, then changed by 0.0% to $7.0 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $7.0 million in Q1 2026, $7.0 million in Q4 2025, and $8.0 million in Q3 2025.